tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
VRNA is currently covered by 2 analysts
Verona Pharma PLC ADR's activity chart (see below) currently has 112 price targets and 86 ratings on display. The stock rating distribution of VRNA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 76.04% with an average time for these price targets to be met of 467.44 days.
Highest price target for VRNA is $107, Lowest price target is $107.
Most recent stock forecast was given by from CANTOR FITZGERALD on 08-Oct-2025. First documented stock forecast 22-May-2017.
Currently out of the existing stock ratings of VRNA, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Jun-2025
$100
9 months 6 days ago
(08-Oct-2025)
2/2 (100%)
$-6.91 (-6.46%)
27
Buy Since 13-Sep-2021
$107
$21 (24.42%)
$90
1 years ago
(14-Jul-2025)
26/27 (96.3%)
$2.33 (2.23%)
282
Buy Since 03-Oct-2024
$107
$21 (24.42%)
$138
1 years 4 days ago
(10-Jul-2025)
4/7 (57.14%)
$2.15 (2.05%)
113
Buy Since 22-May-2017
$77
1 years 4 days ago
(10-Jul-2025)
6/6 (100%)
$27.45 (55.40%)
712
Buy Since 09-Jul-2025
$107
$21 (24.42%)
1 years 5 days ago
(09-Jul-2025)
0/1 (0%)
$2.23 (2.13%)
What is VRNA (Verona Pharma PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?
Which analyst has the most public recommendations on VRNA (Verona Pharma PLC ADR)?
Which analyst is the currently most bullish on VRNA (Verona Pharma PLC ADR)?
Which analyst is the currently most reserved on VRNA (Verona Pharma PLC ADR)?
